ARCHIVES

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

This article is from The Cancer Letter archive.

Vol. 10 No. 10 | March 9, 1984

Download PDF Visit The Full Archive

Related Articles

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

Wiernik Loses Post At Einstein Following Unauthorized Trials

November 5, 1993

NCI-Approved Clinical Trials

July 29, 2005

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991